HK1075832A1 - Use of an alpha helical apolipoprotein of hdl assiociated protein for the manufacture of a medicament adapted to be administered locally to prevent ortreat restenosis - Google Patents
Use of an alpha helical apolipoprotein of hdl assiociated protein for the manufacture of a medicament adapted to be administered locally to prevent ortreat restenosisInfo
- Publication number
- HK1075832A1 HK1075832A1 HK05107947A HK05107947A HK1075832A1 HK 1075832 A1 HK1075832 A1 HK 1075832A1 HK 05107947 A HK05107947 A HK 05107947A HK 05107947 A HK05107947 A HK 05107947A HK 1075832 A1 HK1075832 A1 HK 1075832A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ortreat
- assiociated
- hdl
- restenosis
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32637901P | 2001-09-28 | 2001-09-28 | |
PCT/US2002/031068 WO2003026492A2 (en) | 2001-09-28 | 2002-09-27 | Prevention and treatment of restenosis by local administration of drug |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1075832A1 true HK1075832A1 (en) | 2005-12-30 |
Family
ID=23271954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05107947A HK1075832A1 (en) | 2001-09-28 | 2005-09-09 | Use of an alpha helical apolipoprotein of hdl assiociated protein for the manufacture of a medicament adapted to be administered locally to prevent ortreat restenosis |
Country Status (15)
Country | Link |
---|---|
US (1) | US8119590B2 (xx) |
EP (1) | EP1438060B1 (xx) |
JP (1) | JP2005504085A (xx) |
KR (1) | KR20040081418A (xx) |
CN (2) | CN1943790A (xx) |
AU (1) | AU2002362612B2 (xx) |
BR (1) | BR0212880A (xx) |
CA (1) | CA2460787A1 (xx) |
HK (1) | HK1075832A1 (xx) |
IL (1) | IL161110A0 (xx) |
MX (1) | MXPA04002848A (xx) |
NZ (1) | NZ532217A (xx) |
PL (1) | PL372925A1 (xx) |
WO (1) | WO2003026492A2 (xx) |
ZA (1) | ZA200402548B (xx) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7351421B2 (en) * | 1996-11-05 | 2008-04-01 | Hsing-Wen Sung | Drug-eluting stent having collagen drug carrier chemically treated with genipin |
US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
JP2005504085A (ja) | 2001-09-28 | 2005-02-10 | エスペリオン セラピューティクス,インコーポレイテッド | 薬剤の局所投与による再狭窄の予防および治療 |
AU2003270688A1 (en) * | 2002-10-22 | 2004-05-13 | Wenda Carlyle | Method and agent for treating vulnerable plaque |
US7641643B2 (en) * | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
PE20050438A1 (es) * | 2003-10-20 | 2005-06-14 | Esperion Therapeutics Inc | Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos |
CN1870894B (zh) * | 2003-10-20 | 2011-08-10 | 埃斯普里昂治疗公司 | 用于治疗和预防急性冠状动脉综合征的药物制剂、方法和给药方案 |
CA2544309A1 (en) * | 2003-11-05 | 2005-05-26 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
EP1918000A2 (en) | 2003-11-05 | 2008-05-07 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
EP1699527A1 (en) | 2004-01-02 | 2006-09-13 | Advanced Cardiovascular Systems, Inc. | High-density lipoprotein coated medical devices |
US20050228473A1 (en) * | 2004-04-05 | 2005-10-13 | David Brown | Device and method for delivering a treatment to an artery |
JP2007531537A (ja) * | 2004-04-06 | 2007-11-08 | セダーズ−シナイ メディカル センター | アポリポタンパク質a−iおよびアポリポタンパク質a−imilanoをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置 |
KR20060015963A (ko) * | 2004-08-16 | 2006-02-21 | 주식회사 스텐텍 | 셀레콕십을 포함하는 동맥 재협착 예방 및 치료를 위한 약학 조성물 |
US8206750B2 (en) | 2005-03-24 | 2012-06-26 | Cerenis Therapeutics Holding S.A. | Charged lipoprotein complexes and their uses |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
EP2269623A1 (en) | 2005-04-29 | 2011-01-05 | The Regents of The University of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
US20070254832A1 (en) * | 2006-02-17 | 2007-11-01 | Pressler Milton L | Methods for the treatment of macular degeneration and related eye conditions |
US8785382B2 (en) | 2006-04-03 | 2014-07-22 | Abbott Cardiovascular Systems Inc. | Lipid therapy |
CN101489577B (zh) * | 2006-06-01 | 2013-10-16 | 蒙特利尔心脏病学研究所 | 治疗心瓣膜病的方法和化合物 |
CA2659655A1 (en) | 2006-08-08 | 2008-02-21 | Alan M. Fogelman | Salicylanilides enhance oral delivery of therapeutic peptides |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US20090036965A1 (en) * | 2007-07-30 | 2009-02-05 | Robert Glenmore Walsh | Conjunctive stent therapy |
US20090036875A1 (en) * | 2007-07-30 | 2009-02-05 | Robert Glenmore Walsh | Cardiac tissue therapy |
CN101361980B (zh) * | 2007-08-07 | 2011-07-20 | 山东省生物药物研究院 | 一种适合非注射途径给药的肝素磷脂复合物及其制备方法 |
DK2195331T3 (da) | 2007-08-28 | 2014-02-03 | Uab Research Foundation | Syntetiske polypeptider, der efterligner apolipoprotein e, og anvendelsesmetoder |
US8557767B2 (en) | 2007-08-28 | 2013-10-15 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
US8044021B2 (en) | 2007-09-20 | 2011-10-25 | Abbott Cardiovascular Systems Inc. | Sustained release of apo A-I mimetic peptides and methods of treatment |
US8101565B2 (en) * | 2007-09-20 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US9173890B2 (en) | 2007-09-20 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US7985728B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
US7985727B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Apo A-I mimetic peptides and methods of treatment |
WO2009076272A2 (en) * | 2007-12-07 | 2009-06-18 | Boston Scientific Scimed, Inc. | Drug coated stent with endosome-disrupting conjugate |
US20090297577A1 (en) * | 2008-06-02 | 2009-12-03 | Medtronic Vascular, Inc. | Local Delivery of Apolipoproteins and Their Derivatives |
US8722630B2 (en) * | 2008-06-13 | 2014-05-13 | The General Hospital Corporation | Use of apolipoproteins to decrease inflammation |
SI2396017T1 (sl) | 2009-02-16 | 2015-12-31 | Cerenis Therapeutics Holding Sa | Mimika apolipoproteina A-1 |
BRPI1012910A2 (pt) * | 2009-06-12 | 2020-06-02 | Alphacore Pharma Llc | Uso de um agente que leva a atividade de lcat ou eleva o nível de plasma do lcat ou ambos e composição farmacêutica compreendendo tal agente |
JP5480272B2 (ja) * | 2009-08-27 | 2014-04-23 | テルモ株式会社 | 薬剤送達用医療器具 |
CN101716382B (zh) * | 2009-12-02 | 2015-07-15 | 浙江大学 | 一种质粒dna/纤维蛋白凝胶/聚合物三元复合支架的制备方法 |
PL3178481T3 (pl) | 2010-06-30 | 2019-07-31 | Csl Limited | Odtworzona formulacja lipoproteiny o wysokiej gęstości i sposób jej produkcji |
US20130142760A1 (en) | 2010-08-18 | 2013-06-06 | Cedars-Sinai Medical Center | Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
KR101255337B1 (ko) * | 2010-10-04 | 2013-04-16 | 한국과학기술연구원 | 온도 감응성 합성 고분자를 이용한 일산화질소 전달체 |
CN102240405A (zh) * | 2011-05-09 | 2011-11-16 | 上海市第十人民医院 | ApoA-Ⅰmilano基因药物 |
WO2012166798A2 (en) * | 2011-06-01 | 2012-12-06 | Wake Forest University Health Sciences | Systems and apparatus for indicating risk of coronary stenosis |
MX2014006589A (es) * | 2011-12-21 | 2014-10-17 | Csl Ltd | Régimen de dosificación para formulaciones de apolipoproteína. |
US9610324B2 (en) | 2012-07-11 | 2017-04-04 | Esperion Therapeutics, Inc. | Apolipoprotein mixtures |
US9125943B2 (en) | 2012-11-02 | 2015-09-08 | Csl Limited | Reconstituted HDL formulation |
CN103880949B (zh) * | 2014-03-05 | 2016-09-14 | 王家祥 | 类载脂蛋白c-i及其在制备治疗肾母细胞瘤的药物中的应用 |
RU2016144908A (ru) | 2014-05-02 | 2018-06-05 | Серени Терапеутикс Холдинг Са | Маркеры hdl-терапии |
EP3189069A4 (en) | 2014-07-31 | 2018-03-07 | UAB Research Foundation | Apoe mimetic peptides and higher potency to clear plasma cholesterol |
US11091529B2 (en) | 2014-09-17 | 2021-08-17 | The Regents Of The University Of California | Peptides having reduced toxicity that stimulate cholesterol efflux |
MX2019008529A (es) | 2017-01-19 | 2020-02-07 | Us Health | Peptidos mimeticos de apolipoproteina c-ii (apoc-ii). |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2302698A (en) * | 1941-05-12 | 1942-11-24 | Albert M Kessel | Multiple tissue carrier |
US4009777A (en) * | 1975-12-29 | 1977-03-01 | Ryder International Corporation | Contact lens holder |
US4205747A (en) * | 1978-09-05 | 1980-06-03 | Cilco, Inc. | Lens storage device |
US4277172A (en) * | 1979-11-05 | 1981-07-07 | American Optical Corporation | Soft contact lens apparatus |
US4257521A (en) * | 1979-11-16 | 1981-03-24 | Stanley Poler | Packaging means for an intraocular lens |
US4326306A (en) * | 1980-12-16 | 1982-04-27 | Lynell Medical Technology, Inc. | Intraocular lens and manipulating tool therefor |
US4423809A (en) * | 1982-02-05 | 1984-01-03 | Staar Surgical Company, Inc. | Packaging system for intraocular lens structures |
US4439319A (en) * | 1982-07-16 | 1984-03-27 | Rock John G | Receptacle for the collection of medical specimens and the like |
US4970144A (en) * | 1984-12-31 | 1990-11-13 | International Genetic Engineering | Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
JP2703893B2 (ja) * | 1985-07-05 | 1998-01-26 | ホワイトヘッド・インスティテュ−ト・フォ−・バイオメディカル・リサ−チ | 外来遺伝子物質を発現する上皮細胞 |
GB2189596B (en) * | 1986-04-16 | 1990-08-01 | Pa Consulting Services | Methods of and apparatus for preparing tissue specimens |
US5019084A (en) * | 1986-08-06 | 1991-05-28 | Minnesota Mining And Manufacturing Company | Corneal holder |
US4697697A (en) * | 1986-08-18 | 1987-10-06 | Coopervision, Inc. | Method and apparatus for packaging an intraocular lens |
GB8625435D0 (en) | 1986-10-23 | 1986-11-26 | Erba Farmitalia | Human apolipoprotein ai |
US4750610A (en) * | 1986-12-29 | 1988-06-14 | Ryder International Corporation | Lens case with pressure sensitive venting system |
US4844242A (en) * | 1987-09-02 | 1989-07-04 | The Johns Hopkins University | Cornea retainer |
WO1989007136A2 (en) | 1988-02-05 | 1989-08-10 | Whitehead Institute For Biomedical Research | Modified hepatocytes and uses therefor |
US5972890A (en) * | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
EP0432216A1 (en) | 1988-09-01 | 1991-06-19 | Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
IT1229996B (it) * | 1989-04-20 | 1991-09-20 | Cesare Sirtori | Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine. |
SE468881B (sv) | 1991-01-09 | 1993-04-05 | Kabi Pharmacia Ab | Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar |
SE9103701D0 (sv) * | 1991-12-13 | 1991-12-13 | Kabi Pharmacia Ab | Apolipoprotein |
WO1993018067A1 (en) | 1992-03-06 | 1993-09-16 | Abbott Laboratories | Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels |
WO1994000592A1 (en) | 1992-06-26 | 1994-01-06 | Exocell, Inc. | Monoclonal antibodies against glycated low density lipoprotein |
EP0671926B1 (en) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
US5281227A (en) * | 1992-11-09 | 1994-01-25 | Allergan, Inc. | Lens case with IOL folding device |
US5424040A (en) * | 1992-11-09 | 1995-06-13 | Bjornsson; Bjorn L. | Tissue specimen collection kit |
SE9203753D0 (sv) * | 1992-12-11 | 1992-12-11 | Kabi Pharmacia Ab | Expression system for producing apolipoprotein ai-m |
US5409833A (en) * | 1993-07-01 | 1995-04-25 | Baxter International Inc. | Microvessel cell isolation apparatus |
WO1995023592A1 (en) | 1994-03-04 | 1995-09-08 | The University Of British Columbia | Liposome compositions and methods for the treatment of atherosclerosis |
US6773719B2 (en) * | 1994-03-04 | 2004-08-10 | Esperion Luv Development, Inc. | Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias |
US5643757A (en) * | 1994-03-21 | 1997-07-01 | American Cyanamid Company | High yield production of human apolipoprotein A1 in E. coli. |
US5532168A (en) * | 1994-08-18 | 1996-07-02 | Marantz; Calvin | Tissue biopsy specimen strainer and method |
US5518612A (en) * | 1994-08-30 | 1996-05-21 | Becton, Dickinson And Company | Cell strainer assembly and method of use |
JP3691533B2 (ja) * | 1994-12-07 | 2005-09-07 | 財団法人化学及血清療法研究所 | 抗動脈硬化ペプチド |
SE9500778D0 (sv) * | 1995-03-03 | 1995-03-03 | Pharmacia Ab | Process for producing a protein |
US5609827A (en) * | 1995-05-02 | 1997-03-11 | Beekley Corporation | Biopsy specimen container |
US6258596B1 (en) * | 1995-05-22 | 2001-07-10 | Aventis Pharmaceuticals Products Inc. | Variants of apolipoprotein A-I |
FR2734568B1 (fr) | 1995-05-22 | 1997-06-20 | Rhone Poulenc Rorer Sa | Nouveaux variants de l'apolipoproteine |
US6074614A (en) * | 1995-06-07 | 2000-06-13 | Molecular Devices Corporation | Multi-assay plate cover for elimination of meniscus |
US5928935A (en) * | 1995-09-26 | 1999-07-27 | Reuss, Jr.; William Alexander | Biological specimen containment and incubation device |
US5843474A (en) * | 1995-10-11 | 1998-12-01 | Reverse Transport Licensing & Consulting, Inc. | Method of dialysis treatment, and dialysis apparatus related thereto |
KR0185334B1 (ko) * | 1995-11-02 | 1999-04-01 | 김은영 | 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이 |
GB9609702D0 (en) | 1996-05-09 | 1996-07-10 | Royal Free Hosp School Med | Anticoagulant peptides |
US5817032A (en) * | 1996-05-14 | 1998-10-06 | Biopath Automation Llc. | Means and method for harvesting and handling tissue samples for biopsy analysis |
JPH1025248A (ja) * | 1996-07-08 | 1998-01-27 | Chemo Sero Therapeut Res Inst | 抗血管リモデリング剤 |
SE9603068D0 (sv) * | 1996-08-23 | 1996-08-23 | Pharmacia & Upjohn Ab | Process for purifying a protein |
SE9603303D0 (sv) * | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a protein |
SE9603304D0 (sv) * | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a compound |
GB9620153D0 (en) | 1996-09-27 | 1996-11-13 | Univ Strathclyde | Non-naturally occurring lipoprotein particle |
US7351421B2 (en) * | 1996-11-05 | 2008-04-01 | Hsing-Wen Sung | Drug-eluting stent having collagen drug carrier chemically treated with genipin |
GB9705831D0 (en) | 1997-03-20 | 1997-05-07 | Univ Leicester | Oxidised ldl |
US6635623B1 (en) | 1997-06-13 | 2003-10-21 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
US6727102B1 (en) * | 1997-06-20 | 2004-04-27 | Leuven Research & Development Vzw | Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins |
US6225070B1 (en) | 1997-08-07 | 2001-05-01 | The Regents Of The University Of California | Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
US6004925A (en) * | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6046166A (en) * | 1997-09-29 | 2000-04-04 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6037323A (en) * | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6156315A (en) | 1997-10-10 | 2000-12-05 | The Trustees Of Columbia University In The City Of New York | Method for inhibiting the binding of low density lipoprotein to blood vessel matrix |
EP0911344B1 (en) | 1997-10-15 | 2004-03-03 | Fujirebio Inc. | Anti-Apo-B-48 monoclonal antibody, hybridoma, and methods of use |
US6579682B1 (en) | 1998-03-10 | 2003-06-17 | The Regents Of University Of California | Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan binding |
AU5200699A (en) | 1998-07-13 | 2000-02-01 | University Of Otago | Inhibition of lipoprotein formation |
US6410802B1 (en) * | 1999-04-01 | 2002-06-25 | Esperion Therapeutics, Inc. | Methods for synthesizing ether compounds and intermediates therefor |
US6364098B2 (en) * | 1999-04-09 | 2002-04-02 | Third Millenium Trust | Soft contact lens cleaning and storage system |
DE60045869D1 (de) | 1999-10-26 | 2011-06-01 | Univ California | Reagenzien und verfahren für diagnose, 'imaging' und behandlung von atherosklerotischen krankheiten |
US20020081590A1 (en) | 2000-02-04 | 2002-06-27 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
JP2003525883A (ja) | 2000-03-03 | 2003-09-02 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
SE0000855D0 (sv) | 2000-03-15 | 2000-03-15 | Karolinska Innovations Ab | Antigenic composition useful as a vaccine against atherosclerosis |
GB0017641D0 (en) | 2000-07-18 | 2000-09-06 | Medigene Oy | Peptides and their use |
EP1186299A1 (en) | 2000-09-12 | 2002-03-13 | Universitair Medisch Centrum Utrecht | The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system |
AU2002214644A1 (en) | 2000-10-13 | 2002-04-22 | University Of Cincinnati | Methods for enhancing lysing of coagulated blood with apolipoprotein e2 phenotype |
CA2425513A1 (en) | 2000-10-25 | 2002-06-20 | Vincent Agnello | Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
EP2343317A1 (en) * | 2000-11-10 | 2011-07-13 | F. Hoffmann-La Roche Ltd. | Apolipoprotein analogues |
AU2002241603A1 (en) | 2000-11-10 | 2002-06-03 | University Of Utah Research Foundation | Carrier system for specific artery wall gene delivery |
SE0103754L (sv) | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
RU2003136090A (ru) | 2001-05-15 | 2005-04-20 | Джэпэн Иммьюнорисерч Лэборэтериз Ко., Лтд (Jp) | Пептид, взаимодействующий с липопротеином высокой плотности |
MXPA04000564A (es) | 2001-07-20 | 2005-02-17 | Univ Zuerich | Composiciones y metodos para uso de agentes bioactivos derivados de aminoacidos sulfatados y sulfonados. |
JP2005504085A (ja) | 2001-09-28 | 2005-02-10 | エスペリオン セラピューティクス,インコーポレイテッド | 薬剤の局所投与による再狭窄の予防および治療 |
PE20050438A1 (es) * | 2003-10-20 | 2005-06-14 | Esperion Therapeutics Inc | Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos |
JP2007531537A (ja) | 2004-04-06 | 2007-11-08 | セダーズ−シナイ メディカル センター | アポリポタンパク質a−iおよびアポリポタンパク質a−imilanoをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置 |
-
2002
- 2002-09-27 JP JP2003530138A patent/JP2005504085A/ja active Pending
- 2002-09-27 MX MXPA04002848A patent/MXPA04002848A/es active IP Right Grant
- 2002-09-27 IL IL16111002A patent/IL161110A0/xx unknown
- 2002-09-27 NZ NZ532217A patent/NZ532217A/en unknown
- 2002-09-27 AU AU2002362612A patent/AU2002362612B2/en not_active Ceased
- 2002-09-27 CN CNA2006101537917A patent/CN1943790A/zh active Pending
- 2002-09-27 CN CNB028237811A patent/CN1283313C/zh not_active Expired - Fee Related
- 2002-09-27 CA CA002460787A patent/CA2460787A1/en not_active Abandoned
- 2002-09-27 KR KR10-2004-7004633A patent/KR20040081418A/ko not_active Application Discontinuation
- 2002-09-27 BR BR0212880-2A patent/BR0212880A/pt not_active IP Right Cessation
- 2002-09-27 EP EP02799686.7A patent/EP1438060B1/en not_active Expired - Lifetime
- 2002-09-27 PL PL02372925A patent/PL372925A1/xx not_active Application Discontinuation
- 2002-09-27 WO PCT/US2002/031068 patent/WO2003026492A2/en active Application Filing
- 2002-09-27 US US10/260,094 patent/US8119590B2/en not_active Expired - Fee Related
-
2004
- 2004-03-31 ZA ZA200402548A patent/ZA200402548B/en unknown
-
2005
- 2005-09-09 HK HK05107947A patent/HK1075832A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ532217A (en) | 2006-12-22 |
KR20040081418A (ko) | 2004-09-21 |
JP2005504085A (ja) | 2005-02-10 |
PL372925A1 (en) | 2005-08-08 |
AU2002362612B2 (en) | 2007-11-15 |
US20030109442A1 (en) | 2003-06-12 |
MXPA04002848A (es) | 2005-06-06 |
EP1438060A4 (en) | 2005-09-14 |
CN1283313C (zh) | 2006-11-08 |
IL161110A0 (en) | 2004-08-31 |
US8119590B2 (en) | 2012-02-21 |
ZA200402548B (en) | 2005-05-03 |
CA2460787A1 (en) | 2003-04-03 |
CN1943790A (zh) | 2007-04-11 |
WO2003026492A2 (en) | 2003-04-03 |
EP1438060A2 (en) | 2004-07-21 |
CN1596121A (zh) | 2005-03-16 |
WO2003026492A3 (en) | 2003-10-16 |
EP1438060B1 (en) | 2015-11-11 |
BR0212880A (pt) | 2005-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1075832A1 (en) | Use of an alpha helical apolipoprotein of hdl assiociated protein for the manufacture of a medicament adapted to be administered locally to prevent ortreat restenosis | |
AU2003220317A8 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
AU2003285091A8 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
IL171956A0 (en) | Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis | |
HK1073997A1 (en) | Administration of agents for the treatment of inflammation | |
HK1072558A1 (en) | Methods and dosage forms for controlled delivery of oxycodone | |
HK1068548A1 (en) | Use of omega interferon in the manufacture of a medicament for treating hepatitis c | |
AU2003259381A8 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
EP1404343A4 (en) | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | |
EP1487446A4 (en) | BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES | |
AU5618501A (en) | Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis | |
AU2003243708A1 (en) | Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis | |
IL160780A0 (en) | USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT | |
HUP0303988A2 (hu) | Azitromicin alkalmzása nem fertőző gyulladásos betegségek kezelésére szolgáló gyógyszerkészítmény előállítására | |
SI1487828T1 (sl) | Morfolinil-sečninski derivati za uporabo pri zdravljenu vnetnih bolezni | |
AU2002226427A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
HK1072568A1 (en) | Use of new etonogestrel esters | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
IL160782A0 (en) | USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT | |
HK1076034A1 (en) | Novel association of an antithrombotic agent with aspirin and use thereof for the manufacture of a medicament for treating atherothrombotic diseases | |
PL378197A1 (pl) | Pochodne kwasów indenokarboksylowych oraz ich zastosowanie do leczenia i zapobiegania cukrzycy i dyslipidemii | |
HK1077216A1 (en) | Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease | |
HUP0300876A3 (en) | Use of diclofenac for the manufacture of medicament for the topical treatment of burns | |
GB0212790D0 (en) | Medicament for the treatment of diabetes | |
GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100927 |